Neximmune Inc (NEXI)

Neximmune Inc (NEXI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $139; returns 1 day +0.0%.

NexImmune Inc. is a clinical-stage biotechnology company focused on developing novel T-cell immunotherapies for cancer, autoimmune diseases, and persistent viral infections.

Groups NEXI belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Immunotherapy
• Oncology
• Autologous Cell Therapy
• Hematologic Malignancies
• Preclinical Development

NEXI financial model: income statement, cash flow and balance sheet